NCT05747690View on ClinicalTrials.gov

Evaluation of Performance and Safety of KIO015 in Face Tissue Filling

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

May 4, 2023

Study Completion Date

May 2, 2024

Conditions
Skin Quality
Interventions
DEVICE

KIO015

Innovative carboxymethyl chitosan-based biomaterial intended for intradermal injection

Trial Locations (1)

69100

Eurofins Dermscan Pharmascan, Villeurbanne

Sponsors

Lead Sponsor

Kiomed Pharma
All Listed Sponsors
lead

Kiomed Pharma

INDUSTRY

NCT05747690 - Evaluation of Performance and Safety of KIO015 in Face Tissue Filling | Biotech Hunter | Biotech Hunter